Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Well known Tea Brands for Each Tea Sweetheart - 2Striking American and European television Projects: A Survey
- 3A NASA spacecraft orbiting Mars may be dead
- 4The 12 biggest space stories of 2025 — according to you
- 5The most effective method to Remain Ahead in the Most recent Advanced Patterns with a Web based Advertising Degree
- Joshua Made Last-Second Seat Change That Saved His Life
- EU health regulator urges immediate vaccinations amid early surge in flu cases
- French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
- The Solution to Flexibility: Developing Internal Fortitude Notwithstanding Misfortune
- A Manual for SUVs with Less Noteworthy Gas Mileage
- The Best Cell phone Brands for Tech Aficionados
- What to watch for in weight loss drugs in 2026
- The 10 Most Significant Virtual Entertainment Missions
- Germany's Merz under fire in Brazil for his comments on Amazon host city of COP30
